Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia

International Journal of Obesity

Volumn 31, Issue 1, 2007, Pages 103-108

  Shemesh, T ^a,b,c   Rowley, K G ^c   Jenkins, A ^c   Brimblecombe, J ^a,b   Best, J D ^c   O'Dea, K ^a,c  

^a ROYAL DARWIN HOSPITAL   (Australia)

^b CHARLES DARWIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aboriginal Australians; C reactive protein; Cardiovascular disease; Metabolic abnormalities; Remoteness

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; ARTICLE; AUSTRALIA; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GEOGRAPHY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; TIME SERIES ANALYSIS; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; BODY SIZE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; NORTHERN TERRITORY; OBESITY; OCEANIC ANCESTRY GROUP; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 33845760593     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803350     Document Type: Article

References (42)

1. Australian Institute of Health and Welfare. Australia's Health: Life Expectancy and Longevity. Canberra ACT 2002.
2. Australian Institute of Health and Welfare. The Health and Welfare of Australia's Aboriginal and Torres Strait islander Peoples. Canberra ACT 2003.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340 (2): 115-126.
4. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340 (6): 448-454.
5. Acevedo M, Tagle R, Simpfendorfer C. Non-traditional risk factors for atherosclerosis. Rev Med Chil 2001; 129 (10): 1212-1221.
6. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99 (2): 237-242.
7. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103 (13): 1813-1818.
8. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342 (12): 836-843.
9. Ridker PM, Wilson PWF, Grundy SM. Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk? Circulation 2004; 109 (23): 2818-2825.
10. Sattar N, Gaw A, Scherbakova O, Ford I, Reilly DS, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108 (4): 414-419.
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003; 107 (3): 499-511.
12. Rowley K, Walker KZ, Cohen J, Jenkins AJ, O'Neal D, Su Q et al. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust 2003; 178 (10): 495-500.
13. Lohman TG, Roche AF, Martorell R. Anthropometric standardisation reference manual. Human Kinetic Books: Champaign, IL, 1988. pp. 39-80.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285 (19): 2486-2497.
15. Chaiken RL, Khawaja R, Bard M, Eckert N, Banerji MA, Lebovitz HE. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diab Care 1997; 20 (5): 709-713.
16. Australian Bureau of Statistics. Population distribution, Indigenous Australians Canberra ACT 1996.
17. McDonald S, Maguire G, Duarte N, Wang XL, Hoy W. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. Clin Sci (London) 2004; 106 (2): 121-128.
18. Gardiner DL, Sriprakash KS. Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia. J Clin Microb 1996; 34 (6): 1448-1452.
19. Gillen CM, Towers RJ, McMillan DJ, Delvecchio A, Sriprakash KS, Currie B et al. Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor. Microb 2002; 148 (1): 169-178.
20. Krause V, Reid S, Merianos A. Invasive pneumococcal disease in the Northern Territory of Australia, 1994-1998. Med J Aust 2000; 173 (Suppl 2): s27-s31.
21. Maguire G, Arthur A, Boustead P, Dwyer B, Currie B. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996; 164 (12): 721-723.
22. Black PH. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 2003; 17 (5): 350-364.
23. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epid Comm Health 2003; 57: 730-733.
24. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GDO et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51 (5): 1596-1600.
25. Lee AJ, Bailey AP, Yarmirr D, O'Dea K, Mathews JD. Survival tucker: improved diet and health indicators in an aboriginal community. Aust J Pub Health 1994; 18 (3): 277-285.
26. Lee AJ, O'Dea K, Mathews JD. Apparent dietary intake in remote aboriginal communities. Aust J Pub Health 1994; 18 (2): 190-197.
27. Rowley KG, Su Q, Cincotta M, Skinner M, Skinner K, Pindan B et al. Improvements in circulating cholesterol, antioxidants, and homocysteine after dietary intervention in an Australian Aboriginal community. Am J Clin Nutr 2001; 74 (4): 442-448.
28. Cohen J, Jenkins A, Karschimkus C, Qing S, Lee CT, O'Dea K et al. Paraoxonase and other coronary risk factors in a community-based cohort. Redox Report 2002; 7 (5): 304-307.
29. Barter PJ, Baker PW, Rye KA. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Op Lipod 2002; 13: 285-288.
30. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory Properties of HDL. Circ Res 2004; 95 (8): 764-772.
31. Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Hill E et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Art Thromb Vasc Biol 2001; 21 (9): 1451-1457.
32. Pieroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C. Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diab Metab 2003; 29: 133-138.
33. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282 (22): 2131-2135.
34. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Art Thromb Vasc Biol 2002; 22 (10): 1662-1667.
35. Lee CC, Kasa-Vubu JZ, Supiano MA. Androgenicity and obesity are independently associated with insulin sensitivity in post-menopausal women. Metabolism 2004; 53 (4): 507.
36. Folsom A, Golden S, Boland L, Szklo M. Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal Women. Euro J Epidem 2005; 20 (12): 1015.
37. Piers LS, Rowley KG, Soares MJ, O'Dea K. Relation of adiposity and body fat distribution to body mass index in Australians of Aboriginal and European ancestry. Euro J Clin Nutr 2003; 57 (8): 956-963.
38. Daniel M, Rowley KG, McDermott R, Mylvaganam A, O'Dea K. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diab Care 1999; 22 (12): 1993-1998.
39. Daniel M, Rowley KG, McDermott R, O'Dea K. Diabetes and impaired glucose tolerance in Aboriginal Australians: prevalence and risk. Diab Res Clin Pract 2002; 57 (1): 23-33.
40. Gault A, O'Dea K, Rowley KG, McLeay T, Traianedes K. Abnormal glucose tolerance and other coronary heart disease risk factors in an isolated aboriginal community in central Australia. Diab Care 1996; 19 (11): 1269-1273.
41. O'Dea K, Rowley KG. Macrovascular disease risk factors and insulin resistance in Aboriginal and Torres Strait Islander people. J Diab Compl 2002; 16 (1): 9-16.
42. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Eng J Med 2004; 350 (14): 1387-1397.